What is The Comparative Effectiveness of Targeted Therapy versus Immunotherapy in Terms of Overall Survival, Progression-free Survival, and Quality of Life For Patients With Metastatic Renal Cell Carcinoma? : A Systematic Review and Meta-Analysis . JOC [Internet]. 2025 Nov. 13 [cited 2026 Mar. 3];24(10s):274-99. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1619